BioNeutra Global Corp Cash Flow Conversion Efficiency

Latest as of September 2024: -0.004x

BioNeutra Global Corp cash flow conversion efficiency. Based on the latest financial reports, BioNeutra Global Corp (BGA) has a cash flow conversion efficiency ratio of -0.004x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$33.44K ≈ $24.19K USD) by net assets (CA$-8.23 Million ≈ $-5.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BioNeutra Global Corp (2013–2023)

Cash flow conversion efficiency of BioNeutra Global Corp from 2013 to 2023. This chart illustrates how BioNeutra Global Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BioNeutra Global Corp (BGA) share price today for real-time trading data and today's change.

BioNeutra Global Corp Cash Flow Conversion Ratio Explained

BioNeutra Global Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BioNeutra Global Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioNeutra Global Corp ranked by their cash flow conversion efficiency. Also see BioNeutra Global Corp stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Made Tech Group PLC
LSE:MTEC
0.132x
PHAXIAM Therapeutics S.A.
PA:PHXM
-0.540x
Lucky Minerals Inc
V:LKY
0.000x
Avation PLC
LSE:AVAP
-0.005x
Venture Life Group PLC
LSE:VLG
-0.012x
Antarctica Limited
NSE:ANTGRAPHIC
0.098x
Eurasia Mining
LSE:EUA
0.032x
Team Internet Group PLC
LSE:TIG
0.091x

Annual Cash Flow Conversion Efficiency for BioNeutra Global Corp (2013–2023)

The table below shows the annual cash flow conversion efficiency of BioNeutra Global Corp from 2013 to 2023. Review BGA cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 CA$-6.19 Million
≈ $-4.48 Million
CA$683.42K
≈ $494.37K
-0.110x +50.57%
2022-12-31 CA$-3.76 Million
≈ $-2.72 Million
CA$838.39K
≈ $606.48K
-0.223x +14.85%
2021-12-31 CA$-1.03 Million
≈ $-747.87K
CA$271.05K
≈ $196.07K
-0.262x -112.82%
2020-12-31 CA$700.92K
≈ $507.03K
CA$1.43 Million
≈ $1.04 Million
2.045x +1273.33%
2019-12-31 CA$4.75 Million
≈ $3.44 Million
CA$707.55K
≈ $511.83K
0.149x -7.51%
2018-12-31 CA$18.06 Million
≈ $13.06 Million
CA$2.91 Million
≈ $2.10 Million
0.161x +0.03%
2017-12-31 CA$13.96 Million
≈ $10.10 Million
CA$2.25 Million
≈ $1.62 Million
0.161x +150.02%
2016-12-31 CA$15.78 Million
≈ $11.42 Million
CA$1.02 Million
≈ $734.83K
0.064x +102.99%
2015-12-31 CA$15.19 Million
≈ $10.99 Million
CA$481.50K
≈ $348.31K
0.032x -76.07%
2014-12-31 CA$10.64 Million
≈ $7.70 Million
CA$1.41 Million
≈ $1.02 Million
0.132x -74.65%
2013-12-31 CA$1.93 Million
≈ $1.39 Million
CA$1.01 Million
≈ $728.01K
0.523x --

About BioNeutra Global Corp

V:BGA Canada Packaged Foods
Market Cap
$1.01 Million
CA$1.39 Million CAD
Market Cap Rank
#30669 Global
#1571 in Canada
Share Price
CA$0.03
Change (1 day)
+0.00%
52-Week Range
CA$0.03 - CA$0.03
All Time High
CA$0.90
About

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more